Mission statement · Company scope
“Our mission is to translate our understanding of extracellular tRNA synthetase biology into novel first-in-class drug programs for conditions with unmet patient need.”
In use2018 – now1 sighting
First seenMar 2018Added
Last seenMar 2018Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary)
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Plain
- Length
- 23 words · reading grade 15.4
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.75
- Record
- st_6fec2efaecb871b4
- Classification confidence
- 0.75
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2018-03-20 · sec_sentence · 10-K · accession 0001564590-18-006333
View filing ↗0 to compareCompare